Publications 2007 [References 291–331]

291. Quinn HE, McIntyre PB. Tetanus in the elderly–an important preventable disease in Australia. Vaccine 2007;25:1304-9. [Abstract]

292. Backhouse JL, Gidding HF, MacIntyre CR, McIntyre PB, Gilbert GL. Population-based seroprevalence of Neisseria meningitidis serogroup C capsular antibody before the introduction of conjugat vaccine, in Australia. Vaccine 2007;25:1310-5. [Abstract]

293. Vlack S, Foster R, Menzies R, Williams G, Shannon C, Riley I. Immunisation coverage of Queensland Indigenous two year old children by cluster sampling and by register. Australian and New Zealand Journal of Public Health 2007;31:67-72. [Full text]

294. Booy R, Jelfs J, El Bashir H, Nissen MD. Impact of meningococcal C conjugate vaccine use in Australia [editorial]. Medical Journal of Australia 2007;186:108-9. [Full text]

295. Booy R, Iskander M, Viner R. Prevention of meningococcal disease [letter]. New England Journal of Medicine 2007;356:524-5.[Full text]

296. MacIntyre CR. New developments in BCG vaccine: implications for tuberculosis control [editorial]. Epidemiology and Infection 2007;135:177-80. [No abstract available]

297. Newall A, Beutels P, Wood J, Edmunds WJ, MacIntyre CR. Cost-effectiveness analyses of human papillomavirus vaccination. Lancet Infectious Diseases 2007;7:289-96. [Abstract]

298. Snelling T, Cripps T, Macartney K, Dalton D, Kesson A, Isaacs D. Nosocomial rotavirus infection in an Australian children's hospital [letter]. Journal of Paediatrics and Child Health 2007;43:327. [No abstract available]

299. Gidding HF, Wood J, MacIntyre CR, Kelly H, Lambert SB, Gilbert GL, McIntyre PB. Sustained measles elimination in Australia and priorities for long term maintenance. Vaccine 2007;25:3574-80 [Abstract]

300. Ridda I, MacIntyre CR, Lindley RI, McIntyre PB, Sullivan J, Gilbert G, Kovoor P, Manolios N, Fox J. Predictors of pneumococcal vaccination uptake in hospitalised patients aged 65 years and over shortly following the commencement of a publicly funded national pneumococcal vaccination program in Australia. Human Vaccines 2007;3:57-60. [Abstract]

301. Iskander M, Booy R, Lambert S. The burden of influenza in children. Current Opinion in Infectious Diseases 2007;20:259-63. [Abstract]

302. MacIntyre CR, Burgess M, Isaacs D, McIntyre PB, Menzies R, Hull B. Epidemiology of severe hepatitis A in Indigenous Australian children. Journal of Paediatrics and Child Health 2007;43:383-7. [Abstract]

303. Heron L, Selnikova O, Moiseieva A, van Damme P, van der Wielen M, Levie K, Hoet B, Stoffel M. Immunogenicity, reactogenicity and safety of two-dose versus three-dose (standard care) hepatitis B immunisation of healthy adolescents aged 11–15 years: a randomised controlled trial. Vaccine 2007;25:2817-22. [Abstract]

304. El Bashir H, Rashid H, Memish ZA, Shafi S, Haworth E, Booy R. Meningococcal vaccine coverage in Hajj pilgrims [letter]. Lancet 2007;369:1343. [No abstract available]

305. Wood N, McIntyre P, Elliott E. Pertussis in infancy: a review of strategies for prevention [invited review]. Sociedad Iberoamericana de Informacion Cientifica (SIIC) online. May 2007.

306. Brotherton J. HPV vaccination [letter]. Australian Family Physician 2007;36:391. [No abstract available]

307. Rashid H, Shafi S, El Bashir HE, Haworth E, Memish ZA, Ali KA, Booy R. Influenza and the Hajj: defining influenza-like illness clinically [letter]. International Journal of Infectious Diseases 2007;29 May: Epub ahead of print. [No abstract available]

308. Schmitt HJ, Booy R, Aston R, Van Damme P, Schumacher RF, Campins M, Rodrigo C, Heikkinen T, Weil-Olivier C, Finn A, Olcen P, Fedson D, Peltola H. How to optimise the coverage rate of infant and adult immunisations in Europe. BMC Medicine 2007;5:11 [Full text]

309. Wood JG, Zamani N, MacIntyre CR, Becker NG. Effects of internal border control on spread of pandemic influenza. Emerging Infectious Diseases 2007;13:1038-45. [No abstract available]

310. Teo SS, Ellis JS, Aitken C, Booy R. Transmission of influenza A in families. Pediatric Infectious Disease Journal 2007;26:645-7 [Abstract]

311. Watkins RE, Cooke FC, Donovan RJ, MacIntyre CR, Itzwerth R, Plant AJ. Influenza pandemic preparedness: motivation for protection among small and medium businesses in Australia. BMC Public Health 2007;7:157. [Full text]

312. McIntyre P. Immunisation – success means nothing happens. Australian Health Consumer 2006-2007;(2):20-1. [No abstract available]

313. Hull BP, McIntyre PB. Compliance with three simultaneous vaccinations due at the one visit at 12 months of age in Australia. Communicable Diseases Intelligence 2007;31:198-202. [Full text]

314. Quinn HE, McIntyre PB. Pertussis epidemiology in Australia over the decade 1995–2005 – trends by region and age group. Communicable Diseases Intelligence 2007;31:205-15. [Full text]

315. Schaffer A, Brotherton J, Booy R. Do human papillomavirus vaccines have any role in newborns and the prevention of recurrent respiratory papillomatosis in children? Journal of Paediatrics and Child Health 2007;43:579-80. [No abstract available]

316. Brotherton J, Wang H, Schaffer A, et al. Vaccine preventable diseases and vaccination coverage in Australia, 2003 to 2005. Communicable Diseases Intelligence 2007;31(Suppl):viii-S152. [Full text]

317. Rashid H, Shafi S, Haworth E, El Bashir H, Ali KA, Memish ZA, Booy R. Value of rapid testing for influenza among Hajj pilgrims. Travel Medicine and Infectious Disease 2007;5:310-3. [Abstract]

318. Menzies R, Mcintyre p, O'Brian K, Santosham M, Watt J, Angels G, Brown A, Dunbar M, Crengle S, Lennon D, Mason H, Grim C, Nolan L, Smith P, Dumaresq G, Richardson R, Moberley S, Stirling J, Gooda M, Green M. Conference report: Vaccine preventable diseases in indigenous populations - International perspectives. Satellite Symposium of the %th International Symposium on Pneumococci Pneumococcal Diseases, April 2006, Alice Springs, Australia. Vaccine 2007;25:7281-84.[No abstract available]

319. Lawrence GL, Aratchige PE, Boyd I, McIntyre PB, Gold MS. Annual report on surveillance of adverse events following immunisation in Australia, 2006. Communicable Diseases Intelligence 2007;31:269-83. [Full text]

320. Rank C, Menzies RI. How reliable are Australian Childhood Immunisation Register coverage estimates for Indigenous children? An assessment of data quality and coverage. Communicable Disease Intelligence 2007;31:283-7. [Full text]

321. Heywood AE, Macartney KK, MacIntyre CR, McIntyre PB. Current developments in varicella-zoster virus disease prevention. A report on the varicella-zoster workshop convened by the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases on 16-17 November 2006. Communicable Diseases Intelligence 2007;31:303-10. [Full text]

322. Beutels P, Thiry N, Van Damme P. Convincing or confusing? Economic evaluations of childhood pneumococcal conjugate vaccination-a review (2002–2006). Vaccine 2007;25:1355-67. [Abstract]

323. Owen R, Roche PW, Hope K, Yohannes K, Roberts A, Liu C, Stirzaker S, Kong F, Bartlett M, Donovan B, East I, Fitzsimmons G, McDonald A, McIntyre PB, Menzies RI. Australia's notifiable diseases status, 2005: annual report of the National Notifiable Diseases Surveillance System. Communicable Diseases Intelligence 2007;31:1-70. [Full text]

324. van de Beek D, de Gans J, McIntyre P, Prasad K. Corticosteroids for acute bacterial meningitis [update of Cochrane Database Syst Rev. 2003;(3):CD004405; PMID: 12918010].
Cochrane Database of Systematic Reviews 2007;(1):CD004405. [Abstract]

325. Cameron JC, Allan G, Johnston F, Finn A, Heath PT, Booy R.[[b|| Severe complications of chickenpox in hospitalised children in the UK and Ireland. Archives of Disease in Childhood2007;92:1062-6 [Abstract]

326. Araújo LQ, MacIntyre CR, Vujacich C. Epidemiology and burden of herpes zoster and post-herpetic neuralgia in Australia, Asia and South America. Herpes 2007;14(Suppl 2):40-4. [Abstract]

327. Gunasekera H, Knox S, Morris P, Britt H, McIntyre P, Craig JC. The spectrum and management of otitis media in Australian Indigenous and nonIndigenous children: a national study. Pediatric Infectious Disease Journal 2007;26:689-92. [Abstract]

328. Gidding HF, Warlow M, MacIntyre CR, Backhouse J, Gilbert GL, Quinn HE, McIntyre PB. The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia. Vaccine 2007;25:8637-41. [Abstract]

329. Newall AT, Beutels P, Macartney K, Wood J, MacIntyre CR. The cost-effectiveness of rotavirus vaccination in Australia. Vaccine 2007;25:8851-60. [Abstract]

330. Seale H, MacIntyre R, Dwyer D, Wang H. The changing epidemiology of severe cytomegalovirus disease in Australia. Human Vaccines 2007;3:239-44. [Abstract]

331. Ladhani SN, Booy R. Host genetic susceptibility to infection. In: Nadel S (ed). Infectious diseases in the pediatric intensive care unit. London: Springer-Verlag, 2007. [No abstract available]